Wishlist
Shopping Cart
-
Your cart is empty!
Looks like you haven't added anything to your cart yet. Please add some items to proceed.
Subtotal:
£0.00
7 people currently viewing
Tirzepatide - 5mg
GB
GB from London bought this product.
Secure Checkout
Lab Checked
Fast UK Delivery
Category:
Product Description
Product
Tirzepatide - 5mg
Category
Peptides
Rating
5.0 / 5.0
Price
£75.00
What is it?
Tirzepatide 5mg is a dual GLP-1 and GIP receptor agonist (the world's first 'twincretin') that has demonstrated superior weight loss outcomes compared to Semaglutide alone in clinical trials. It is approved as Mounjaro for type 2 diabetes and Zepbound for obesity.
Price
£75.00
Availability
In Stock
Active Ingredient
Tirzepatide
Product Form
Lyophilised peptide for subcutaneous injection
Primary Use
Weight loss; metabolic health; blood glucose management; superior fat loss vs single-agonist GLP-1 agents
Available Dosages
5mg per vial
Common Side Effects
Nausea, diarrhoea, vomiting (typically transient), constipation, abdominal discomfort, injection site reactions. Similar contraindications to Semaglutide regarding thyroid/MEN2
Who is This Product Suitable For
Individuals seeking powerful medically-supported weight loss. Suitable for overweight adults and those with type 2 diabetes. Not suitable for those with MEN2 or personal history of medullary thyroid cancer
Benefit
Superior weight loss vs single-agonist GLP-1 agents
Benefit
Dual GLP-1/GIP mechanism
Benefit
Improved insulin sensitivity
Benefit
Significant cardiovascular metabolic benefits
Benefit
Weekly injection
What is it?
Tirzepatide 5mg is a dual GLP-1 and GIP receptor agonist (the world's first 'twincretin') that has demonstrated superior weight loss outcomes compared to Semaglutide alone in clinical trials. It is approved as Mounjaro for type 2 diabetes and Zepbound for obesity.
Price
£75.00
Availability
In Stock
Active Ingredient
Tirzepatide
Product Form
Lyophilised peptide for subcutaneous injection
Primary Use
Weight loss; metabolic health; blood glucose management; superior fat loss vs single-agonist GLP-1 agents
Available Dosages
5mg per vial
Common Side Effects
Nausea, diarrhoea, vomiting (typically transient), constipation, abdominal discomfort, injection site reactions. Similar contraindications to Semaglutide regarding thyroid/MEN2
Who is This Product Suitable For
Individuals seeking powerful medically-supported weight loss. Suitable for overweight adults and those with type 2 diabetes. Not suitable for those with MEN2 or personal history of medullary thyroid cancer
Benefit
Superior weight loss vs single-agonist GLP-1 agents
Benefit
Dual GLP-1/GIP mechanism
Benefit
Improved insulin sensitivity
Benefit
Significant cardiovascular metabolic benefits
Benefit
Weekly injection
